Trial NCT03057626

Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

This research trial studies late effects after treatment in patients with previously
diagnosed high-risk neuroblastoma. Studying late effects after treatment may help to decide
which treatments for high-risk neuroblastoma are better tolerated with less side effects over
time.

Intervention

Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Quality-of-Life Assessment

Condition

Recurrent Neuroblastoma, Stage 2A Neuroblastoma, Stage 2B Neuroblastoma, Stage 3 Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma

Investigators

Tara O Henderson

See list of participating sites